Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma

scientific article

Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V11.I30.4655
P932PMC publication ID4615406
P698PubMed publication ID16094705
P5875ResearchGate publication ID292388252

P2093author name stringWei Wu
Deng-Fu Yao
Jian-Hua Zhu
Xian-Yong Meng
Xin-Hua Wu
Deng-Bing Yao
Li-Wei Qiu
Dao-Rong Jiang
Zhi-Zhen Dong
P2860cites workMembers of the human glyceraldehyde-3-phosphate dehydrogenase-related gene family map to dispersed chromosomal locationsQ28279849
Angiogenesis in health and diseaseQ29614541
Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinomaQ31148803
The IGF axis and hepatocarcinogenesisQ33918694
A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.Q34124264
Cancer epidemiology in the last century and the next decadeQ34253597
Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinomaQ34655130
The prognostic molecular markers in hepatocellular carcinomaQ34668320
Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesinQ34792237
Hepatitis B virus genotypes and hepatocellular carcinoma in JapanQ35612676
The role of the IGF axis in hepatocarcinogenesisQ35622480
PTEN modulates insulin-like growth factor II (IGF-II)-mediated signaling; the protein phosphatase activity of PTEN downregulates IGF-II expression in hepatoma cellsQ40639993
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective studyQ40650650
Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinomaQ40860429
The role of insulin-like growth factor II in the malignant transformation of rat liver oval cellsQ41119539
Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in ChinaQ42981714
Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sitesQ43031257
Incidence of hepatitis C virus (HCV) antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze RiverQ43036016
Virological features of hepatitis C virus infection in patients with liver diseases in the inshore area of the Yangtze RiverQ43036251
Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma. An in situ hybridization and immunohistochemical studyQ45141524
The expression of insulin-like growth factor II, hepatitis B virus X antigen and p21 in experimental hepatocarcinogenesis in tree shrews.Q45748850
Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expressionQ45783000
Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liverQ47872943
Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activityQ47886447
In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma.Q48019186
Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.Q53427783
Human insulin-like growth factor I and II messenger RNA: isolation of complementary DNA and analysis of expressionQ69452823
Differential expression of transforming growth factor a and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinomaQ71870169
Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinomaQ72511270
Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic ratsQ73002025
Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liverQ73107790
Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinomaQ73321524
Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinomaQ73459294
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinomaQ74093462
Molecular pathogenesis of human hepatocellular carcinomaQ74543031
Expression of insulin-like growth factor II mRNA in hepatocellular carcinomaQ77379667
P433issue30
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)4655-4660
P577publication date2005-08-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleExpression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma
P478volume11

Reverse relations

cites work (P2860)
Q46553511Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis
Q85224661Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular Carcinoma
Q37534945Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
Q36011412Circulating tumor cells measurements in hepatocellular carcinoma
Q40316507Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients
Q37327775Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells
Q33866121Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma
Q39034561Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma
Q37503151Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats
Q52558393Insulin-Like Growth Factor (IGF) System in Liver Diseases.
Q37047067Insulin-like growth factor: current concepts and new developments in cancer therapy
Q47113848MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma
Q42936819Molecular mechanisms of progression in human hepatocarcinogenesis
Q37113552Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.
Q90326478Relationship between Metal Pollution and Gene Expression of Insulin-like Growth Factor II
Q37809251Signaling Networks in Human Hepatocarcinogenesis—Novel Aspects and Therapeutic Options
Q40214305Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma
Q27006846Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
Q34182483The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets
Q36960897Trace element concentration in primary liver cancers--a systematic review

Search more.